BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 19302977)

  • 21. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.
    Szczyrba J; Nolte E; Wach S; Kremmer E; Stöhr R; Hartmann A; Wieland W; Wullich B; Grässer FA
    Mol Cancer Res; 2011 Jun; 9(6):791-800. PubMed ID: 21593139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells.
    Yao Q; Xu H; Zhang QQ; Zhou H; Qu LH
    Biochem Biophys Res Commun; 2009 Oct; 388(3):539-42. PubMed ID: 19682430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells.
    Liu L; Chen L; Xu Y; Li R; Du X
    Biochem Biophys Res Commun; 2010 Sep; 400(2):236-40. PubMed ID: 20727858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3.
    He L; Yao H; Fan LH; Liu L; Qiu S; Li X; Gao JP; Hao CQ
    Genet Mol Res; 2013 Apr; 12(2):1012-21. PubMed ID: 23613247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
    Liu M; Wu H; Liu T; Li Y; Wang F; Wan H; Li X; Tang H
    Cell Res; 2009 Jul; 19(7):828-37. PubMed ID: 19546886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
    Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L
    Cancer Res; 2009 Jul; 69(14):5761-7. PubMed ID: 19584283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion.
    Li Q; Wang G; Shan JL; Yang ZX; Wang HZ; Feng J; Zhen JJ; Chen C; Zhang ZM; Xu W; Luo XZ; Wang D
    J Gastroenterol Hepatol; 2010 Jan; 25(1):164-71. PubMed ID: 19793168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme.
    Li Y; Li W; Yang Y; Lu Y; He C; Hu G; Liu H; Chen J; He J; Yu H
    Brain Res; 2009 Aug; 1286():13-8. PubMed ID: 19559015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression.
    Micallef J; Taccone M; Mukherjee J; Croul S; Busby J; Moran MF; Guha A
    Cancer Res; 2009 Oct; 69(19):7548-56. PubMed ID: 19773446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
    FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The mechanism of apoptosis in human U87 glioma cells induced by miR-21 antisense oligonucleotide].
    Shi L; Cheng Z; Zhang J; Li R; You Y; Fu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):497-501. PubMed ID: 18841558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer.
    Yoshino H; Enokida H; Chiyomaru T; Tatarano S; Hidaka H; Yamasaki T; Gotannda T; Tachiwada T; Nohata N; Yamane T; Seki N; Nakagawa M
    Biochem Biophys Res Commun; 2012 Jan; 417(1):588-93. PubMed ID: 22178073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration.
    Li X; Shen Y; Ichikawa H; Antes T; Goldberg GS
    Oncogene; 2009 Dec; 28(48):4272-83. PubMed ID: 19767772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines.
    Ifere GO; Barr E; Equan A; Gordon K; Singh UP; Chaudhary J; Igietseme JU; Ananaba GA
    Cancer Detect Prev; 2009; 32(4):319-28. PubMed ID: 19186008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells.
    Borralho PM; Kren BT; Castro RE; da Silva IB; Steer CJ; Rodrigues CM
    FEBS J; 2009 Nov; 276(22):6689-700. PubMed ID: 19843160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.
    Mertens-Talcott SU; Chintharlapalli S; Li X; Safe S
    Cancer Res; 2007 Nov; 67(22):11001-11. PubMed ID: 18006846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FTY720, a fungus metabolite, inhibits invasion ability of androgen-independent prostate cancer cells through inactivation of RhoA-GTPase.
    Zhou C; Ling MT; Kin-Wah Lee T; Man K; Wang X; Wong YC
    Cancer Lett; 2006 Feb; 233(1):36-47. PubMed ID: 16473668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of myopodin expression reduces invasion and motility of PC-3 prostate cancer cells.
    De Ganck A; De Corte V; Bruyneel E; Bracke M; Vandekerckhove J; Gettemans J
    Int J Oncol; 2009 May; 34(5):1403-9. PubMed ID: 19360353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. microRNA-330 inhibits cell motility by downregulating Sp1 in prostate cancer cells.
    Mao Y; Chen H; Lin Y; Xu X; Hu Z; Zhu Y; Wu J; Xu X; Zheng X; Xie L
    Oncol Rep; 2013 Jul; 30(1):327-33. PubMed ID: 23670210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways.
    Chung S; Furihata M; Tamura K; Uemura M; Daigo Y; Nasu Y; Miki T; Shuin T; Fujioka T; Nakamura Y; Nakagawa H
    Oncogene; 2009 Aug; 28(32):2849-59. PubMed ID: 19483721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.